ABCG2 Localizes to the Nucleus and Modulates CDH1 Expression in Lung Cancer Cells

Neoplasia (United States)

Volumn 17, Issue 3, 2015, Pages 265-278

  Liang, Shu Ching ^a   Yang, Chih Yung ^b   Tseng, Ju Yu ^a   Wang, Hong Ling ^a   Tung, Chien Yi ^a   Liu, Hong Wen ^a   Chen, Chin Yau ^a   Yeh, Yi Chen ^c   Chou, Teh Ying ^a,c   Yang, Muh Hwa ^a,c   Whang Peng, Jacqueline ^d,e   Lin, Chi Hung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; UVOMORULIN; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; CADHERIN; CDH1 PROTEIN, HUMAN; TUMOR PROTEIN;

A549 CELL LINE; ANIMAL EXPERIMENT; ARTICLE; CELL FRACTIONATION; CELL MEMBRANE; CELL MIGRATION; CELL NUCLEUS; CIRCULATING TUMOR CELL; E BOX ELEMENT; GENE EXPRESSION; GENE SILENCING; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; TRANSCRIPTION REGULATION; ACTIVE TRANSPORT; ANIMAL; BIOLOGICAL MODEL; CELL ADHESION; CELL MOTION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LUNG TUMOR; MALE; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR EMBOLISM; XENOGRAFT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASTIC CELLS, CIRCULATING; RNA INTERFERENCE; TRANSCRIPTION, GENETIC;

EID: 84964694891     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2015.01.004     Document Type: Article

References (51)

1. [1] American Cancer Society, Cancer Facts & Figures. 2013, American Cancer Society, Atlanta, GA.
2. [2] Schinkel, AH, Jonker, JW, Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55 (2003), 3–29.
3. [3] Dean, M, ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia 14 (2009), 3–9.
4. [4] Robey, R, Polgar, O, Deeken, J, To, K, Bates, S, ABCG2: determining its relevance in clinical drug resistance. Cancer Metastasis Rev 26 (2007), 39–57.
5. [5] Hirschmann-Jax, C, Foster, AE, Wulf, GG, Nuchtern, JG, Jax, TW, Gobel, U, Goodell, MA, Brenner, MK, A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 101 (2004), 14228–14233.
6. [6] Ho, MM, Ng, AV, Lam, S, Hung, JY, Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 67 (2007), 4827–4833.
7. [7] Visvader, JE, Lindeman, GJ, Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8 (2008), 755–768.
8. [8] Zhou, S, Schuetz, JD, Bunting, KD, Colapietro, AM, Sampath, J, Morris, JJ, Lagutina, I, Grosveld, GC, Osawa, M, Nakauchi, H, et al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7 (2001), 1028–1034.
9. [9] Yoh, K, Ishii, G, Yokose, T, Minegishi, Y, Tsuta, K, Goto, K, Nishiwaki, Y, Kodama, T, Suga, M, Ochiai, A, Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non–small cell lung cancer. Clin Cancer Res 10 (2004), 1691–1697.
10. [10] Ota, S, Ishii, G, Goto, K, Kubota, K, Kim, YH, Kojika, M, Murata, Y, Yamazaki, M, Nishiwaki, Y, Eguchi, K, et al. Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy. Lung Cancer 64 (2009), 98–104.
11. [11] Solazzo, M, Fantappie, O, D'Amico, M, Sassoli, C, Tani, A, Cipriani, G, Bogani, C, Formigli, L, Mazzanti, R, Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines. Cancer Res 69 (2009), 7235–7242.
12. [12] Lemos, C, Kathmann, I, Giovannetti, E, Dekker, H, Scheffer, GL, Calhau, C, Jansen, G, Peters, GJ, Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco-2 cells. Int J Cancer 123 (2008), 1712–1720.
13. [13] Chen, JS, Pardo, FS, Wang-Rodriguez, J, Chu, TS, Lopez, JP, Aguilera, J, Altuna, X, Weisman, RA, Ongkeko, WM, EGFR regulates the side population in head and neck squamous cell carcinoma. Laryngoscope 116 (2006), 401–406.
14. [14] Yeboah, D, Kalabis, GM, Sun, M, Ou, RC, Matthews, SG, Gibb, W, Expression and localisation of breast cancer resistance protein (BCRP) in human fetal membranes and decidua and the influence of labour at term. Reprod Fertil Dev 20 (2008), 328–334.
15. [15] Bhatia, P, Bernier, M, Sanghvi, M, Moaddel, R, Schwarting, R, Ramamoorthy, A, Wainer, IW, Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells. Xenobiotica 42 (2012), 748–755.
16. [16] Yang, MH, Hsu, DS, Wang, HW, Wang, HJ, Lan, HY, Yang, WH, Huang, CH, Kao, SY, Tzeng, CH, Tai, SK, et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 12 (2010), 982–992.
17. [17] Yang, CY, Kuo, TH, Ting, LP, Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response. J Biol Chem 281 (2006), 34525–34536.
18. [18] Dennis, G Jr., Sherman, BT, Hosack, DA, Yang, J, Gao, W, Lane, HC, Lempicki, RA, DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4 (2003), R60.1–R60.11.
19. [19] Thiery, JP, Sleeman, JP, Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7 (2006), 131–142.
20. [20] Huang, WC, Chen, YJ, Li, LY, Wei, YL, Hsu, SC, Tsai, SL, Chiu, PC, Huang, WP, Wang, YN, Chen, CH, et al. Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells. J Biol Chem 286 (2011), 20558–20568.
21. [21] Xie, Y, Xu, K, Linn, DE, Yang, X, Guo, Z, Shimelis, H, Nakanishi, T, Ross, DD, Chen, H, Fazli, L, et al. The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. J Biol Chem 283 (2008), 3349–3356.
22. [22] Mogi, M, Yang, J, Lambert, JF, Colvin, GA, Shiojima, I, Skurk, C, Summer, R, Fine, A, Quesenberry, PJ, Walsh, K, Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J Biol Chem 278 (2003), 39068–39075.
23. [23] Bleau, AM, Hambardzumyan, D, Ozawa, T, Fomchenko, EI, Huse, JT, Brennan, CW, Holland, EC, PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. Cell Stem Cell 4 (2009), 226–235.
24. [24] Huang, FF, Wu, DS, Zhang, L, Yu, YH, Yuan, XY, Li, WJ, Chen, XP, Zhao, XL, Chen, FP, Zeng, H, Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia. Cancer Lett 336 (2013), 96–105.
25. [25] Baldini, N, Scotlandi, K, Serra, M, Shikita, T, Zini, N, Ognibene, A, Santi, S, Ferracini, R, Maraldi, NM, Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Eur J Cell Biol 68 (1995), 226–239.
26. [26] Hennig, G, Löwrick, O, Birchmeier, W, Behrens, J, Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem 271 (1996), 595–602.
27. [27] Hosono, S, Gross, I, English, MA, Hajra, KM, Fearon, ER, Licht, JD, E-cadherin is a WT1 target gene. J Biol Chem 275 (2000), 10943–10953.
28. [28] Cano, A, Perez-Moreno, MA, Rodrigo, I, Locascio, A, Blanco, MJ, del Barrio, MG, Portillo, F, Nieto, MA, The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2 (2000), 76–83.
29. [29] Batlle, E, Sancho, E, Franci, C, Dominguez, D, Monfar, M, Baulida, J, Garcia de Herreros, A, The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2 (2000), 84–89.
30. [30] Comijn, J, Berx, G, Vermassen, P, Verschueren, K, van Grunsven, L, Bruyneel, E, Mareel, M, Huylebroeck, D, van Roy, F, The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 7 (2001), 1267–1278.
31. [31] Hajra, KM, Chen, DY-S, Fearon, ER, The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 62 (2002), 1613–1618.
32. [32] Yang, J, Mani, SA, Donaher, JL, Ramaswamy, S, Itzykson, RA, Come, C, Savagner, P, Gitelman, I, Richardson, A, Weinberg, RA, Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117 (2004), 927–939.
33. [33] Frixen, UH, Behrens, J, Sachs, M, Eberle, G, Voss, B, Warda, A, Löchner, D, Birchmeier, W, E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113 (1991), 173–185.
34. [34] Wendt, MK, Taylor, MA, Schiemann, BJ, Schiemann, WP, Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Mol Biol Cell 22 (2011), 2423–2435.
35. [35] Chao, Y, Shepard, C, Wells, A, Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer 9 (2010), 1–18.
36. [36] Chaffer, CL, Brennan, JP, Slavin, JL, Blick, T, Thompson, EW, Williams, ED, Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res 66 (2006), 11271–11278.
37. [37] Dykxhoorn, DM, Wu, Y, Xie, H, Yu, F, Lal, A, Petrocca, F, Martinvalet, D, Song, E, Lim, B, Lieberman, J, miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS One 4 (2009), 1–14 [e7181].
38. [38] Wu, K, Fan, J, Zhang, L, Ning, Z, Zeng, J, Zhou, J, Li, L, Chen, Y, Zhang, T, Wang, X, et al. PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription. Cell Signal 24 (2012), 2273–2282.
39. [39] Stankic, M, Pavlovic, S, Chin, Y, Brogi, E, Padua, D, Norton, L, Massagué, J, Benezra, R, TGF-β-Id1 signaling opposes twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition. Cell Rep 5 (2013), 1228–1242.
40. [40] Kim, M, Turnquist, H, Jackson, J, Sgagias, M, Yan, Y, Gong, M, Dean, M, Sharp, JG, Cowan, K, The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin Cancer Res 8 (2002), 22–28.
41. [41] Scharenberg, CW, Harkey, MA, Torok-Storb, B, The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99 (2002), 507–512.
42. [42] Krishnamurthy, P, Ross, DD, Nakanishi, T, Bailey-Dell, K, Zhou, S, Mercer, KE, Sarkadi, B, Sorrentino, BP, Schuetz, JD, The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 279 (2004), 24218–24225.
43. [43] Korpal, M, Ell, BJ, Buffa, FM, Ibrahim, T, Blanco, MA, Celia-Terrassa, T, Mercatali, L, Khan, Z, Goodarzi, H, Hua, Y, et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 17 (2011), 1101–1108.
44. [44] Celia-Terrassa, T, Meca-Cortes, O, Mateo, F, de Paz, AM, Rubio, N, Arnal-Estape, A, Ell, BJ, Bermudo, R, Diaz, A, Guerra-Rebollo, M, et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J Clin Invest 122 (2012), 1849–1868.
45. [45] Ocana, OH, Corcoles, R, Fabra, A, Moreno-Bueno, G, Acloque, H, Vega, S, Barrallo-Gimeno, A, Cano, A, Nieto, MA, Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 22 (2012), 709–724.
46. [46] Tsai, JH, Donaher, JL, Murphy, DA, Chau, S, Yang, J, Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 22 (2012), 725–736.
47. [47] Li, R, Liang, J, Ni, S, Zhou, T, Qing, X, Li, H, He, W, Chen, J, Li, F, Zhuang, Q, et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7 (2010), 51–63.
48. [48] Samavarchi-Tehrani, P, Golipour, A, David, L, Sung, HK, Beyer, TA, Datti, A, Woltjen, K, Nagy, A, Wrana, JL, Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7 (2010), 64–77.
49. [49] Chang, CC, Hsu, WH, Wang, CC, Chou, CH, Kuo, MY, Lin, BR, Chen, ST, Tai, SK, Kuo, ML, Yang, MH, Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. Cancer Res 73 (2013), 4147–4157.
50. [50] Gong, W, Wang, Z, Wan, Y, Shi, L, Zhou, Y, Downregulation of ABCG2 protein inhibits migration and invasion in U251 glioma stem cells. Neuroreport 25 (2014), 625–632.
51. [51] Shi, L, Wang, Z, Sun, G, Wan, Y, Guo, J, Fu, X, miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2. Neuromolecular Med 16 (2014), 517–528.